We are live on ! Find out more
ELTX icon

Elicio Therapeutics
ELTX

37 hedge funds and large institutions have $16.6M invested in Elicio Therapeutics in 2025 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 4

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

32% more funds holding

Funds holding: 28 → 37 (+9)

0.19% more ownership

Funds ownership: 11.7% → 11.89% (+0.19%)

21% less capital invested

Capital invested by funds: $20.9M → $16.6M (-$4.32M)

89% less call options, than puts

Call options by funds: $291K | Put options by funds: $2.59M

Holders
37
Holders Change
+9
Holders Change %
+32.14%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
10
Reduced
5
Closed
4
Calls
$291K
Puts
$2.59M
Net Calls
-$2.3M
Net Calls Change
-$3.93M

Top Buyers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
+$512K
2
Marshall Wace
Marshall Wace
United Kingdom
+$278K
3
UBS Group
UBS Group
Switzerland
+$227K
4
OAC
OMERS Administration Corp
Ontario, Canada
+$213K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$209K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$510K
2
CAM
Cresset Asset Management
Illinois
-$295K
3
Millennium Management
Millennium Management
New York
-$250K
4
Renaissance Technologies
Renaissance Technologies
New York
-$187K
5
Citigroup
Citigroup
New York
-$117K
Name Holding Trade Value Shares
Change 		Change in
Stake
MLL
26
Moody Lynn & Lieberson
Massachusetts
$79.6K – – –
P
27
&Partners
Tennessee
$79.6K – – –
CIBC Private Wealth Group
28
CIBC Private Wealth Group
Georgia
$55.7K – – –
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
$45.1K +$51.4K +5,668 New
SPIA
30
Steward Partners Investment Advisory
New York
$12.4K – – –
Bank of America
31
Bank of America
North Carolina
$9.21K -$22K -2,428 -68%
FFA
32
Farther Finance Advisors
California
$5.61K +$590 +65 +10%
Group One Trading
33
Group One Trading
Illinois
$2.57K +$2.93K +323 New
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$2K +$1.99K +219 New
Wells Fargo
35
Wells Fargo
California
$1.59K – – –
FFO
36
Fortitude Family Office
Arizona
$740 +$844 +93 New
SS
37
SBI Securities
Japan
$653 – – –
CAM
38
Cresset Asset Management
Illinois
– -$295K -26,925 Closed
Millennium Management
39
Millennium Management
New York
– -$250K -22,846 Closed
Citigroup
40
Citigroup
New York
– -$117K -10,658 Closed
Simplex Trading
41
Simplex Trading
Illinois
– -$935 -103 Closed
1
2

ELTX Hedge Fund Activity: Q4 2025 in Review

37 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Elicio Therapeutics (ELTX) for Q4 2025, worth a combined $16.6M — down 21% from $20.9M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ELTX positions and 4 closed out — a net gain of 9 holders — while 10 added to existing stakes and 5 trimmed.

The largest buyer was 683 Capital Management, opening a new position worth an estimated $512K. The largest seller was Susquehanna International Group, cutting an estimated $510K.

  • 37 institutional investors held Elicio Therapeutics (ELTX) as of Q4 2025, up from 28 in Q3 2025.
  • Funds reported $16.6M of Elicio Therapeutics stock for Q4 2025, down 21% quarter-over-quarter.
  • 13 funds opened new Elicio Therapeutics positions in Q4 2025 and 4 closed out, a net change of +9 holders.
  • The largest Elicio Therapeutics buyer in Q4 2025 was 683 Capital Management, an estimated $512K added.
  • The largest Elicio Therapeutics seller in Q4 2025 was Susquehanna International Group, an estimated $510K sold.

Based on aggregated 13F filings for Q4 2025.